Latest Wockhardt stock price
Wockhardt P/E Ratio
WOCKPHARMA • P/E ratio not applicable due to negative earnings
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Current EPS: ₹-3.02
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | 4.81 | 82 | Profit |
| Mar 2025 | -1.57 | -45 | Loss |
| Jun 2025 | -5.53 | -108 | Loss |
| Sept 2024 | -1.47 | -16 | Loss |
| Mar 2024 | -11.64 | -177 | Loss |
| Jun 2024 | -0.95 | -16 | Loss |
| Dec 2024 | 0.91 | 20 | Profit |
| Sept 2023 | -5.37 | -73 | Loss |
Profitable Companies in Healthcare Sector
Other profitable companies in Healthcare sector with valid P/E ratios
Sector Average PE
57.32
Sector Median PE
35.38
Lowest PE
9.01
Profitable Companies
89
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |
| Lincoln Pharmaceuticals | LINCOLN | 12.02 | ₹974 | Low |
| QMS Medical Allied Servi… | QMSMEDI | 12.82 | ₹177 | Low |
| Take Solutions | TAKE | 13.15 | ₹638 | Low |
| Venus Remedies | VENUSREM | 14.27 | ₹995 | Low |
| Royal Sense | ROYAL | 14.5 | ₹96 | Low |
| Bliss GVS Pharma | BLISSGVS | 16.62 | ₹1,973 | Moderate |
| RPG Life Sciences | RPGLIFE | 17.94 | ₹3,861 | Moderate |